KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Income from Continuing Operations (2016 - 2025)

Astrana Health's Income from Continuing Operations history spans 16 years, with the latest figure at 1078000.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 94.32% year-over-year to 1078000.0; the TTM value through Sep 2025 reached 9737000.0, down 83.1%, while the annual FY2024 figure was 49932000.0, 13.69% down from the prior year.
  • Income from Continuing Operations for Q3 2025 was 1078000.0 at Astrana Health, down from 10215000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 60821000.0 in Q2 2021 and bottomed at 18152000.0 in Q4 2021.
  • The 5-year median for Income from Continuing Operations is 11450000.0 (2022), against an average of 11657315.79.
  • The largest annual shift saw Income from Continuing Operations skyrocketed 543.85% in 2022 before it crashed 8262.37% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 18152000.0 in 2021, then soared by 95.14% to 883000.0 in 2022, then surged by 89.47% to 93000.0 in 2023, then plummeted by 8262.37% to 7777000.0 in 2024, then surged by 113.86% to 1078000.0 in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Income from Continuing Operations are 1078000.0 (Q3 2025), 10215000.0 (Q2 2025), and 6221000.0 (Q1 2025).